Global Coronary Artery Bypass Graft Surgery – Medical Devices Pipeline Assessment, 2017

“The Report Coronary Artery Bypass Graft Surgery – Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz”

About Coronary Artery Bypass Graft Surgery Market

GlobalData’s Medical Devices sector report, Coronary Artery Bypass Graft Surgery – Medical Devices Pipeline Assessment, 2017″ provides an overview of Coronary Artery Bypass Graft Surgery currently in pipeline stage.

Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1326339

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Coronary Artery Bypass Graft Surgery pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Coronary Artery Bypass Graft Surgery under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Coronary Artery Bypass Graft Surgery and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

View Sample PDF @ https://www.marketresearchreports.biz/reports/1326339/coronary-artery-bypass-graft-surgery-medical-devices-pipeline-assessment-2017-market-research-reports.pdf

Reasons to buy

The report enables you to –

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of Coronary Artery Bypass Graft Surgery under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the products current stage of development, territory and estimated launch date

View Report @ https://www.marketresearchreports.biz/reports/1326339/coronary-artery-bypass-graft-surgery-medical-devices-pipeline-assessment-2017-market-research-reports

Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 7

2 Introduction 8

2.1 Coronary Artery Bypass Graft Surgery Overview 8

3 Products under Development 9

3.1 Coronary Artery Bypass Graft Surgery – Pipeline Products by Stage of Development 9

3.2 Coronary Artery Bypass Graft Surgery – Pipeline Products by Segment 10

3.3 Coronary Artery Bypass Graft Surgery – Pipeline Products by Territory 11

3.4 Coronary Artery Bypass Graft Surgery – Pipeline Products by Regulatory Path 12

3.5 Coronary Artery Bypass Graft Surgery – Pipeline Products by Estimated Approval Date 13

3.6 Coronary Artery Bypass Graft Surgery – Ongoing Clinical Trials 14

4 Coronary Artery Bypass Graft Surgery – Pipeline Products under Development by Companies 15

4.1 Coronary Artery Bypass Graft Surgery Companies – Pipeline Products by Stage of Development 15

4.2 Coronary Artery Bypass Graft Surgery – Pipeline Products by Stage of Development 17

5 Coronary Artery Bypass Graft Surgery Companies and Product Overview 18

5.1 AdvanSource Biomaterials Corporation Company Overview 18

5.1.1 AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview 18

5.2 Axcelon Biopolymers Corp. Company Overview 19

5.2.1 Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview 19

5.3 CardioPolymers Inc Company Overview 20

5.3.1 CardioPolymers Inc Pipeline Products & Ongoing Clinical Trials Overview 20

5.4 Cardious, Inc. Company Overview 21

5.4.1 Cardious, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21

5.5 CellProthera Company Overview 22

5.5.1 CellProthera Pipeline Products & Ongoing Clinical Trials Overview 22

5.6 Coromedic Ltd. Company Overview 25

5.6.1 Coromedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview 25

5.7 Cytograft Tissue Engineering Inc (Inactive) Company Overview 27

5.7.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 27

5.8 Elana bv Company Overview 28

5.8.1 Elana bv Pipeline Products & Ongoing Clinical Trials Overview 28

5.9 Endogene Ltd Company Overview 30

5.9.1 Endogene Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

5.10 Graft-Loc Inc. Company Overview 31

5.10.1 Graft-Loc Inc. Pipeline Products & Ongoing Clinical Trials Overview 31

5.11 H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview 32

5.11.1 H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.12 Humacyte Inc Company Overview 33

5.12.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 33

5.13 iiTech BV Company Overview 34

5.13.1 iiTech BV Pipeline Products & Ongoing Clinical Trials Overview 34

5.14 LeMaitre Vascular Inc Company Overview 36

5.14.1 LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.15 Magenta Medical Inc Company Overview 37

5.15.1 Magenta Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 37

5.16 McGill University Company Overview 38

5.16.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview 38

5.17 Miracor Medical Systems GmbH Company Overview 39

5.17.1 Miracor Medical Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview 39

5.18 Neograft Technologies Inc Company Overview 42

5.18.1 Neograft Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 42

5.19 Nice University Hospital Company Overview 45

5.19.1 Nice University Hospital Pipeline Products & Ongoing Clinical Trials Overview 45

5.20 NuVascular Technologies Inc Company Overview 46

5.20.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 46

5.21 Palmaz Scientific Inc (Inactive) Company Overview 47

5.21.1 Palmaz Scientific Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 47

5.22 PetVivo Holdings Inc Company Overview 48

5.22.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 48

5.23 Prekubator TTO Company Overview 49

5.23.1 Prekubator TTO Pipeline Products & Ongoing Clinical Trials Overview 49

5.24 RegenMedTX LLC Company Overview 50

5.24.1 RegenMedTX LLC Pipeline Products & Ongoing Clinical Trials Overview 50

5.25 Revivicor Inc Company Overview 51

5.25.1 Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview 51

5.26 Rox Medical Inc Company Overview 52

5.26.1 Rox Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 52

5.27 SeamVad Ltd. Company Overview 53

5.27.1 SeamVad Ltd. Pipeline Products & Ongoing Clinical Trials Overview 53

5.28 The University of Utah Company Overview 54

5.28.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 54

5.29 Thoratec Corp Company Overview 55

5.29.1 Thoratec Corp Pipeline Products & Ongoing Clinical Trials Overview 55

5.30 Tissue Regeneration Technologies LLC Company Overview 56

5.30.1 Tissue Regeneration Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 56

5.31 University College London Company Overview 57

5.31.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 57

5.32 University of Arizona Company Overview 58

5.32.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 58

5.33 University of California Los Angeles Company Overview 59

5.33.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 59

Send An Enquiry Request @ https://www.marketresearchreports.biz/sample/enquiry/1326339

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074

Website: http://www.marketresearchreports.biz/

E: sales@marketresearchreports.biz

Designed by CyFocus.com
Powered by CyFocus.net
%d bloggers like this: